Days after receiving U.S. Food and Drug Administration (FDA) approval, the Abbott ALK test for non-small-cell lung cancer (NSCLC) has become available in the United States, European Union and New Zealand.

Early reports indicating drugs treating psoriasis were linked to major cardiovascular events seem to lack evidence.

Childhood and adolescent bullying, particularly at school, is a growing problem for our youth. Since the shootings at Columbine High School in 1999, the severity and tragic consequences of bullying has received more attention.

People living in poor countries have minimal access to basic healthcare, and sophisticated cancer tests are non-existent. Researchers are developing a device that could change that.

The younger a smoker is that decides to quit, obviously the better for their health. Women in their golden years can receive immediate benefits from quitting.

The battle against the power of cancer is being waged largely on the genetic front these days. Scientists have discovered another gene that could be targeted to treat two forms of the disease.

For patients with coronary disease, taking medication to prevent blood clots for up to two years provides no additional benefit in avoiding adverse heart events as compared to taking it for six months.

A virus that's in the rabies family holds promise in fighting a rare but lethal form of cancer found in children and young adults. Yale University researchers are working with this virus as a potential treatment.

With ragweed season having already arrived in most parts of the country, many decide not to treat their allergies or assume they just have a cold or sinus infection.

The 9/11 nightmare lives on in the bodies - as well as the minds - of firefighters who were on the scene that fateful day. New research shows these heroes live with increased risks of cancer.